Φορτώνει......
MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
Gastric cancer remains a disease with a dismal prognosis. Extensive efforts to find targetable disease drivers in gastric cancer were implemented to improve patient outcomes. Beyond anti-HER2 therapy, MET pathway seems to be culprit of cancer invasiveness with MET-overexpressing tumors having poorer...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Exp Pharmacol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547764/ https://ncbi.nlm.nih.gov/pubmed/33116950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S242958 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|